Life science companies are responding with Real World Evidence (RWE) programs to capture data from clinical through post-market activities from a variety of sources. Learn how the centralization of data assets enables organizational intelligence by equipping companies to understand the needs of patients and other stakeholders, and how their products can meet them. Download this Whitepaper!
The conference will bring together high-level executives, industry leaders, policy makers, entrepreneurs, academics and investors from around the globe to debate trends, navigate industry challenges, access innovative companies, conduct business meetings, and discover new connection opportunities. Register Now!
RESI Healthtech Week, a three-day event, whose first day highlights life science companies of the First Coast who are seeking grants, seed, and angel funding. RESI Healthtech Week dedicates day one and two for one-on-one partnering and includes exhibiting, networking, workshops, classes, and panels. Day three, the last day, will be the Entrepreneur’s Academy Workshop series for all global attendees. It is a full day of classes and workshops focused on branding, researching investors, and fundraising—everything the emerging entrepreneur needs. Register today.
Registration link: http://www.resihealthtechweek.com/
This webinar will present a quantitative systems pharmacology case study which assesses a Lipid Nanoparticle to treat Crigler-Najjar Syndrome Type 1. Learn how the model was used to support translation from preclinical to clinical trials as well as first-in-human dosing.
Navigating patient-reported outcomes (PROs) such as unobservable symptoms, treatment satisfaction, quality of life, and treatment adherence is a critical component of a patient centric healthcare system. Join our experts in the first of a three-part webinar series on PROs, as they provide insight on the foundational elements of PROs and recent regulatory trends. Register now!
One year ago, Thermo Fisher Scientific completed the acquisition of Patheon, creating the world’s most comprehensive and sophisticated end-to-end CDMO partner. But what does that mean to the industry today?
MASS West 2018 is designed to provide attendees with a platform to develop a unified scientific voice and ultimately help position your medical affairs group as a strategic, customer-facing function. Register Here!
Join CBI’s 4th Annual Bio/Pharmaceutical Product Launch Summit to analyze each step that’s necessary to innovatively plan for a new product launch, such as identifying the keys to early commercialization, eliminate barriers to market access, harness new technology and ensure post-launch success. Register today!
Join 300+ biotech executives for unequaled networking and strategy-setting. Optimize partnerships, secure investors, and accelerate R&D. 90+ speakers and 10+ hours of networking prepare you to guide your company towards the best partnerships for drug development! Register today with the code: FIERCE100 for $100 off at registration!
Join 1000+ attendees for the largest event exclusively for digital marketing for the life sciences. Our faculty of 140+ industry experts will be leading informative sessions filled with real-world examples and actionable insights over four days of interactive learning and networking. Register with code FPL100 to save $100 on your registration!
CBI’s Speed to IND for Biologics assembles bioprocessing experts and academics from every department to share their perspectives, achievements and lessons learned, to build a community working towards the common goal of accelerating biologic manufacturing while managing and mitigating risk. Register today.
The BIO Investor Forum is an international biotech investor conference focused on investment opportunities in life sciences, with emphasis on venture-stage growth and emerging public companies as well as those poised to join the growth “watch-list” in 2019. Fierce subscribers save $200 on registration. Request your code here.
It has been and big year for gene therapy. This webinar will review Commissioner Gottlieb’s statement, provide an overview of the six guidance documents, and discuss the implications for development of new gene therapy products from the perspective of regulatory strategy, clinical development, pharmacology/toxicology considerations, and CMC development.
Join FierceBiotech in London this October 30th for an engaging half-day Executive Summit. We'll gather industry experts together to discuss the infrastructures of biomedical science across the United Kingdom and the challenges and opportunities to boosting life sciences amid a time of major change as the U.K. approaches a future outside of the European Union. Register now!
This webinar will help you understand what is involved in an NDA including regulatory strategy, data integration and readiness, and electronic publishing, and provide tips that can help you avoid common pitfalls in the submissions process.
Download this FREE whitepaper for comparative data and valuable insider insights that pharma companies should consider for their products and marketing strategies.
There is a remarkable scientific research revolution underway: technology that facilitates highly-personalized research workflows is being developed and will soon become mainstream. Far more valuable than simply presenting information, personalized access tools will help the researcher make the best of available content by pinpointing to what’s important. Download this eBrief to learn how personalization will dramatically improve the way researchers in all fields are able to work.
Participate in this short, ten minute survey on data access and analytics in health plans today. Input from professionals in the field is important, and we appreciate your participation.
The Barnett Institute at Northeastern University and BioAnalytix are hosting an annual summit focused on the advanced development of biologic therapeutics. Hear about Opportunities in Integrating Characterization, CMC and Clinical Program Data from leaders at the FDA, Amgen, and Roche-Genentech. Register Today!
As the number of clinical trials increases so does the complexity and number of US and global sites needed to foster trial success. Read what was discovered after a survey on current site payment practices, how these practices are measured, what process improvement initiatives are currently being explored, what are some of the barriers to change, and what site payment trends will occur over the next five years. Download it now!
Built on a reputation of excellence and founded in science, PDA courses provide professionals with education to foster career development. This fall, explore courses on visual inspection, regulatory compliance, sterilization, pre-filled syringes, pharmaceutical microbiology, validation, and more. Register today!
Join your fellow Senior-Level Finance and Accounting Executives in Boston on September 25-26 at industry’s leading CPE accredited event dedicated to the distinct business needs of pioneering and emerging small-middle sized life sciences companies. Register today!
The challenges for new drugs looking to enter the market are numerous, especially in small molecule development. Learn how one of the best ways to stay on-schedule is to start with a solid understanding of the most common API challenges before they affect your timeline. Download Today!
Selecting the right sites is the most crucial decision you’ll make in your next clinical trial, and the single most important factor to consider in selecting a site is whether or not it can meet its enrollment goals. So, how do sponsors determine the best-fit sites for their studies? Download the whitepaper to find out.
As the biopharmaceutical industry continues to evolve, the Quality by Design (QbD) holistic and proactive approach to drug development and manufacturing is transforming key processes. Learn how sponsors who implement QbD early can same time, money, and improve quality. Download Now!
Develop a basic understanding of principles and concepts of bioavailability of oral drugs. This course, designed for scientists involved in pharmaceutical drug development, will simplify the concepts of bioavailability and how to manage biopharmaceutical challenges, and identify why it is an important factor in optimal therapies for patients. Enroll Now!
Download this infographic for comparative data and valuable insider insights on dermatology drug adherence that pharma companies should consider for their products and marketing strategies.
Download this playbook to find out how gamification can drive business goals like improving adherence, increasing health literacy, and inspiring brand loyalty. Click here to download now.
Take this quick 10 minute survey on the state of sales enablement in the healthcare industry. A $5 Amazon Gift Card will be sent to the first 50 qualified respondents. Complete the survey now!
Hear new results from one of the industry's largest, global clinical operations surveys, the Veeva 2018 Unified Clinical Operations Survey. The Veeva 2018 Unified Clinical Operations Survey examines the industry’s progress toward a unified clinical operating environment.
Learn why unifying clinical applications is an industrywide priority for clinical operations leaders. Read the report.
Research tells us that the role of patient-physician communication is a key factor that can impact adherence.
Download this Infographic to learn how Atlantis Healthcare uses health psychology to improve patient-physician communication and drive higher rates of treatment adherence.
Sponsors, CROs, and other developers can no longer afford the delays and high costs of inefficient clinical research practices. Adopting a unified trial platform- powered by a larger standardized data -- can reduce timelines, cost and get products to patients sooner. Download the Whitepaper now.
Ready to modernize your RIM environment? Secure buy-in with these tips. Download Today!
Join Joe Lipari, Director - Global Traceability from Systech, as we map out a proven route to serialization success along with Steve Kane, Head of Product Integrity Program Global IT for Shire and Ann Schaefer, Director - Supply Chain Management at Acorda Therapeutics. The panel will discuss complexity of the regulations, hurdles they overcame, and solutions that carried them over the finish line. Register Now.
To elevate the customer experience in real-time, Pharma organizations must deploy strategies that cut through the market noise and engage customers with a higher degree of customization. Learn the right tools to implement that enable commercial teams to be more collaborative, scalable, and knowledgeable. Register now!
Where is the medical cost trend headed in 2019? PwC’s Health Research Institute (HRI) annually projects the growth of medical costs in the employer insurance market for the coming year and identifies the leading factors expected to impact the trend. Uncover the factors impacting medical cost trend - from provider megamergers and physician employment trends to healthy advocacy and the increasing customer centricity of healthcare - and what it means for providers, payers, pharma/life sciences companies and employers. Register now!
Researchers are encumbered with a plethora of disparate data and analytic tools. These assets pose several challenges which need to be overcome to ensure they satisfy their intended purpose.
Watch this webinar to learn how real-time, self-service access to longitudinal patient data is changing the way researchers evaluate treatment effectiveness, safety, protocol design, and more. Register now.
What’s the best strategy to create a holistic syringe-based combination product performance testing program? Start with the fundamentals - ISO and USP considerations. Join West packaging and performance experts as they explain how fit-for-purpose syringe-based combination product packaging involves holistic consideration and testing. Register now!
Fraud and fabrication is no laughing matter in the realm of clinical trials.
This webinar will outline the ways in which sponsors and CROs can remain diligent, by being aware of signs of possible fraud and fabricated data, throughout the course of the study. Register now.
“Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-strapped companies whose hopes hinge upon one or two molecules. Read how CDMOs are responding to this pressure.
Expanding an existing portfolio with lifecycle management strategies does involve some expense, but it’s not nearly as expensive as developing an entirely new drug. Learn about some new areas of exploration, including novel drug combinations and more. Read the whitepaper to learn more.
Watch our experts as they provide insight on how to plan and complete the state licensing application process to ensure the successful launch of your product. Key objectives of the webinar include:
- Factors in the determination of State Licensing requirements
- Types of Distribution Models
- Timing from regulatory application submission to distribution
The new EU HTA Directive requires consistent comparative clinical efficacy assessment of EMA assessed treatments. Understand the history of the Directive, what is included, the proposed structure and timing, potential implications for industry and stakeholders, and how to prepare. Register now.
Watch this webinar and discover what best practices sponsors and CROs should follow when evaluating a current or future investigator payments partner. Register here.
How is ICH GCP E6 R2 making it easier for patients to receive the right treatment at the right time? This webinar will explore the essential elements of RBM, straight from the drawing board of ICH E6 R2 working group, and RBM's role in addressing complexities in oncology clinical trials with a roadmap to get ahead. Register now!
This webinar will discuss several capsule formulations used in DPIs and will compare their performance. It will provide an overview on some of the novel methods being employed to evaluate the physical characteristics and mechanical properties of capsules, and will also address the factors influencing the aerosolisation performance of different capsule types. Register Now
Download this infographic for comparative data and valuable insider insights on rheumatology drug adherence that pharma companies should consider for their products and marketing strategies.
This webinar will share ways to overcome the potential hurdles of a tech transfer project, and will present a case study of global-tech transfer with fast track approval. Learn more, and register, here!
Read a case study on how to utilize a parallel screening approach to selecting a most suitable formulation technology for an early phase BCS Class II compound. The molecule was advanced to animal study with enhanced bioavailability in 12 weeks.
Watch a video to learn how to incorporate everything you need to progress you drug candidate from late stage discovery to phase I into one comprehensive offering which can quickly help achieve your milestone
Advancing beyond Phase I can be exciting – and eye opening – for clinical sponsors. By examining study factors known to be leading indicators of future clinical supply challenges, sponsors can take a proactive approach to clinical supplies, build realistic timelines and better forecast demand.
Study sponsors often focus on upfront planning to ensure clinical sites are prepared to reach study milestones but ignore the logical challenges of managing their clinical returns. Learn how developing a forward-thinking plan to manage clinical returns can reduce study close out risk.
Download this Infographic for comparative data and valuable insider insights on neurology drug adherence that pharma companies should consider for their products and marketing strategies.
Download this Infographic for comparative data and valuable insider insights on gastrointestinal drug adherence that pharma companies should consider for their products and marketing strategies.
Biomanufacturing summarizes the key steps of a manufacturing campaign, including cell line development, cell banking, scale-up, quality aspects, harvesting and purification. Understand the pathway from lab to production. Register today!
Read Deloitte Consulting's whitepaper on the value of a holistic RIM capability, covering the potential cost savings and revenue gains from doing RIM right.
A case of 29X increase in relative effectiveness
Dave Taylor, director of market research at Inspire, describes case studies illustrating how life science companies can reduce the time it takes to conduct research by accessing a website that millions of patients flock to. Learn more.
Gartner research on preparing for IDMP
While the deadline for IDMP compliance is delayed, life sciences IT leaders supporting regulatory compliance can use this research to establish value-adding strategies for the short – and long – term. Read it now.